Total submissions: 7
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Gene |
RCV000827372 | SCV000969015 | likely benign | not provided | 2019-08-12 | criteria provided, single submitter | clinical testing | |
Invitae | RCV001416065 | SCV001618235 | likely benign | Dilated cardiomyopathy 1G; Autosomal recessive limb-girdle muscular dystrophy type 2J | 2022-08-20 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002345918 | SCV002647018 | likely benign | Cardiovascular phenotype | 2019-09-09 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Fulgent Genetics, |
RCV002507451 | SCV002807985 | likely benign | Dilated cardiomyopathy 1G; Autosomal recessive limb-girdle muscular dystrophy type 2J; Tibial muscular dystrophy; Myopathy, myofibrillar, 9, with early respiratory failure; Early-onset myopathy with fatal cardiomyopathy; Hypertrophic cardiomyopathy 9 | 2021-10-28 | criteria provided, single submitter | clinical testing | |
CHEO Genetics Diagnostic Laboratory, |
RCV003150358 | SCV003838542 | likely benign | Cardiomyopathy | 2021-09-24 | criteria provided, single submitter | clinical testing | |
Ce |
RCV000827372 | SCV004703336 | likely benign | not provided | 2024-01-01 | criteria provided, single submitter | clinical testing | TTN: BP4, BP7 |
Prevention |
RCV004540127 | SCV004792989 | likely benign | TTN-related disorder | 2019-03-05 | criteria provided, single submitter | clinical testing | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |